Skip to main content
. Author manuscript; available in PMC: 2014 Jul 17.
Published in final edited form as: Dev Dyn. 2009 Jul;238(7):1760–1767. doi: 10.1002/dvdy.22000

Table 1. Mutations in the Prx2/S8-binding site and their effects on EGFP expression in the ventricle.

Construct EGFP Expression
P234: 5′-CTAAATTAGCCCTCCGCTATCAGAGAA 12% (n = 140)
P234M1: 5′-CTAAATTCCCCCTCCGCTATCAGAGAA 0% (n = 126)
P234M2: 5′-CTAAACCAGCCCTCCGCTATCAGAGAA 0% (n = 130)
P234M3: 5′-CTAAATTAGGGCTCCGCTATCAGAGAA 2% (n = 118)
P234M4: 5′-CCCAATTAGCCCTCCGCTATCAGAGAA 2% (n = 109)
P234M5: 5′-CTAAATTAGCCCTCCGCCCTCAGAGAA 10% (n = 105)

Underlined: Prx2/S8 consensus binding site. n: total number of microinjections for each construct.